The biotech play behind three takeovers worth $83 billion

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Strategic Tech Investor. Your ability to alter your subscription information can be found at the bottom of this email. [Strategic Tech Investor] [Alpha-9 AI Technology Exposing Opportunities That Can Be Worth Thousands (in Extra Cash)]( If you'd had the benefit of Alpha-9 a few weeks ago, you could have pocketed $2,775 on Monday, $2,575 on Tuesday, $4,350 on Wednesday, $3,125 on Thursday, and $2,975 on Friday. In fact, with the unprecedented moneymaking power of Alpha-9, you place trades in five minutes that can help you make thousands of dollars in extra cash every day the markets are open. [Click here]( to learn how Alpha-9 can help make you a millionaire in the next 12 months. --------------------------------------------------------------- January 18, 2019 [The Biotech Play Behind Three Takeovers Worth $83 Billion]( [(Click here to view this report online.)]( By Michael A. Robinson Dear Strategic Tech Investor Reader, LATEST REPORT --------------------------------------------------------------- [sti-report-cover]( LATEST APPEARANCE --------------------------------------------------------------- [What's Next For Apple?]( MICHAEL'S LATEST ALERTS --------------------------------------------------------------- Research [We're Making Big Gains - And Protecting Them]( Trading [Why We're Catching This Medical Data Firm at Just the Right Time]( Until Jan. 7, most investors had never heard of a small biopharmaceutical firm based out of Stamford, Ct. But they certainly paid attention to Loxo Oncology Inc. ([Nasdaq:LOXO]() and its medicines for patients with genetically defined cancers after its stock jumped more than 66% that day. Of course, within minutes, the average retail investor was locked out of the action. That's because shares of this once-obscure biotech leader leapt on news of an $8 billion buyout from Eli Lily & Co. ([NYSE:LLY](). See, the biopharma giant is shelling out the money to gain access to Loxo's cutting-edge cancer treatment. As important as the news is for life sciences investors, in all candor I probably wouldn't be bringing it to your attention if this was just a one-off. That's because this was the third major biotech takeover in just a few weeks' time. And when I say major... the total price tag for all three deals... was a cool $83 billion. Talk about a sector on fire with mergers and acquisitions. Which leads me to the theme at hand... Finding a good way to profit from of all of this M&A activity in the life sciences sector... without getting blindsided by these eye-popping deals, like we saw with the Loxo Oncology takeover. So today, I'm going to let you in on how to profit from takeovers in the space, with an investment that has already rallied nearly 21% from its recent low... [Check it out](... Here's what else I'm following... --------------------------------------------------------------- [Attention: FCC Approval Could Spark the Next Generation of New Millionaires]( The FCC has given its blessing... The Washington Times says it will "change the world on a scale hardly seen in human history." And here at our headquarters, we believe this could very well be [the single event that sends this company's stock SOARING](... Steven Mnuchin Just Jerked Wall Street's Slipperiest Chain Treasury Secretary Steven Mnuchin just shined a very bright light on a very dark corner of Wall Street. In a recent Bloomberg interview, Mnuchin tip-toed around the real narrative of today's "market structure," which is nothing more than a vacuum-sealed bubble, ready to pop. And when it does, you're not going to want to be on the wrong side of the implosion... [click here]( to read the full story and sign up for Wall Street Insights and Indictments - this is something you don't want to miss. [Your access to America's #1 Pattern Trader Cash Course (for just $1)]( This [seven-day Cash Course]( covers all the essential trading ideas you NEED to know to get the most out of your potential profits in 2019. And not only will I review the basics, I'll share dozens of [my most lucrative secrets]( to potentially start collecting anywhere from $1,190, $1,313, and even $2,830 in consistent income - each and every week. All of this and more can be yours for only $1. [Full story](... [Three Top Tech Buys in 2019]( The tech-centric Nasdaq took a nosedive, plunging into bear-territory right before Christmas. It's the best time to buy these stocks, because when they rally - and they will - [we're looking at massive returns.]( [U.S. General Admits Shocking Truth: Russia Has "Unstoppable" New Secret Weapon]( In a riveting speech to the Senate Armed Services Committee, General John Hyten, Chief of U.S. Air Force Strategic Command, made a shocking confession: The United States is now virtually defenseless against a new Russian weapon that could destroy New York or Washington in minutes. When you [see this new threat](, you'll know why top ranking U.S. Generals can't sleep at night. WARNING: [This video]( contains graphic content. YOU MAY HAVE MISSED... --------------------------------------------------------------- [This crackdown is changing the crypto world forever (here's what you need to know)]( [Are you entitled to this lump-sum payout?]( [Your $1 million payday opportunity awaits]( [This fuel's TOTAL DOMINANCE of the energy markets is inescapable]( --------------------------------------------------------------- [Facebook]( [Twitter]( [More...]( mailto:?subject=Michael%20Robinson's%20Strategic%20Tech%20Investor&body=Check%20out%20http%3A%2F%2Fwww.strategictechinvestor.com%2F You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Strategic Tech Investor. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Strategic Tech Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2019 Strategic Tech Investor All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Strategic Tech Investor. 1125 N Charles Street, Baltimore MD 21201.